Author: Ethan Gregory - Page 2

Kombucha contains trace alcohol that can dangerously interact with medications like metronidazole, SSRIs, and diabetes drugs. Learn which meds are at risk, how much alcohol is really in kombucha, and what steps to take to stay safe.

Pharmacists are now key providers of vaccines and affordable generic medications, offering accessible, trusted care that bridges gaps in the healthcare system. Learn how their advocacy is reshaping public health.

People with chronic kidney disease are at high risk for acute kidney injury from contrast dye and common medications like NSAIDs. Learn how to avoid these triggers and protect your kidneys with simple, proven steps.

Telehealth is transforming how rural patients manage medication side effects, reducing hospital visits and saving lives. Learn how remote monitoring works, what tools are used, and how to get started - even with limited internet.

Most sinus infections are viral and don’t need antibiotics. Learn how to tell the difference between viral and bacterial sinusitis, when antibiotics actually help, and what to do instead to recover safely.

The first generic drug company to file an ANDA with a Paragraph IV certification gets 180 days of exclusive market rights under the Hatch-Waxman Act. This incentive drives competition but has been exploited to delay generic access.

Switching health plans? Don't overlook generic drug coverage. A small change in formulary tiers can cost you hundreds. Learn how to check your meds, avoid surprise costs, and save money on prescriptions.

Long-term steroid use can silently cause cataracts and glaucoma-even if you feel fine. Learn how steroid eye damage happens, who’s at risk, and the simple monitoring steps that can save your vision.

Learn when medication side effects typically appear - from minutes to months after taking a drug. Understand the timeline for allergic reactions, rashes, and chronic issues so you know when to act.

Paragraph IV certifications let generic drug makers legally challenge brand-name patents before market entry. This Hatch-Waxman tool drives competition, lowers drug prices, and offers 180-day exclusivity to the first challenger.